The Administrators of the Tulane Educational Fund;McGill University
发明人:
Bowers, Cyril Y.,Coy, David H.,Hocart, Simon J.,Tannenbaum, Gloria S.
申请号：
AU2011268256
公开号：
AU2011268256A1
申请日:
2011.06.16
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention provides novel peptides that can modulate the ghrelin receptor (growth hormone secretagogue receptor, GHS-R1a and subtypes, isoforms and variants thereof). These peptides are useful as antagonists of the ghrelin receptor as well as inverse agonist, partial agonist or a combination of these activities as medicaments for treatment and prevention of a range of medical conditions including, but not limited to, metabolic and/or endocrine disorders, gastrointestinal disorders, cardiovascular disorders, obesity and obesity-associated disorders, diabetes, central nervous system disorders, genetic disorders, and hyperproliferative disorders.
